Randomized Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
Status:
Not yet recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the effects of semaglutide on kidney
oxygenation and function in type 1 diabetes. The secondary objective is to determine the
glycemic effects and safety of semaglutide in type 1 diabetes.
Phase:
Phase 2
Details
Lead Sponsor:
University of Washington
Collaborators:
Juvenile Diabetes Research Foundation Providence Healthcare University of Colorado, Denver University of Toronto